DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

The Westin Arlington

2025 年 04 月 07 日 7:00 上午 - 2025 年 04 月 08 日 4:00 下午

801 N. Glebe Road, Arlington, VA 22203, USA

Global Labeling Conference

Join speakers from around the world sharing their labeling expertise!

Early Bird Rates Expire

DAYS

HOURS

MINUTES

SECONDS

Session 8: Will Artificial Intelligence (AI) Transform Drug Labeling Processes?

Session Chair(s)

Deborah  Bebbington

Deborah Bebbington

Head Global Labeling

Bayer Plc, United Kingdom

Mary Beth  Wilusz

Mary Beth Wilusz

Head, Regulatory Labeling Operations and Compliance

Daiichi Sankyo, Inc., United States

This session will examine the transformative role of artificial intelligence (AI), neuro linguistic programming (NLP), and machine learning (ML) in global regulatory labeling, highlighting opportunities to enhance efficiency, accuracy, and compliance. Speakers will discuss how these technologies can streamline processes, from automating label updates to analyzing health authority requirements, while addressing challenges such as integration and data privacy. Attendees will gain insights into how AI-driven innovations are reshaping labeling processes, future directions in the industry, and strategies for collaborating with health authorities to navigate the evolving regulatory landscape.

Learning Objective :
  • Gain an understanding of how to structure prompts to generate appropriate AI output
  • Identify specific areas of the labeling process that can benefit from the use AI, NLP or ML
  • Evaluate the future role and potential of AI in the regulatory labeling landscape

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。